• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

重组凝血因子Ⅶ表达和合成机制的研究进展

彭林, 于笑, 蔡燕飞, 金坚, 李华钟

彭林, 于笑, 蔡燕飞, 金坚, 李华钟. 重组凝血因子Ⅶ表达和合成机制的研究进展[J]. 中国药科大学学报, 2015, 46(5): 623-628. DOI: 10.11665/j.issn.1000-5048.20150518
引用本文: 彭林, 于笑, 蔡燕飞, 金坚, 李华钟. 重组凝血因子Ⅶ表达和合成机制的研究进展[J]. 中国药科大学学报, 2015, 46(5): 623-628. DOI: 10.11665/j.issn.1000-5048.20150518
PENG Lin, YU Xiao, CAI Yanfei, JIN Jian, LI Huazhong. Research advances of recombinant coagulation factor VII expression and synthesizing mechanism[J]. Journal of China Pharmaceutical University, 2015, 46(5): 623-628. DOI: 10.11665/j.issn.1000-5048.20150518
Citation: PENG Lin, YU Xiao, CAI Yanfei, JIN Jian, LI Huazhong. Research advances of recombinant coagulation factor VII expression and synthesizing mechanism[J]. Journal of China Pharmaceutical University, 2015, 46(5): 623-628. DOI: 10.11665/j.issn.1000-5048.20150518

重组凝血因子Ⅶ表达和合成机制的研究进展

基金项目: 国家高技术研究发展计划(863计划)资助项目(No.2014AA021003)

Research advances of recombinant coagulation factor VII expression and synthesizing mechanism

  • 摘要: 血友病是由于人体内缺乏相应凝血因子造成的凝血障碍,目前主要利用基因重组技术在不同细胞中表达重组凝血因子Ⅶ(Ⅶ因子)从而对血友患者出血进行治疗。为有效提高重组Ⅶ因子的产量及活性,已有研究者尝试利用不同真核表达系统合成重组Ⅶ因子,如BHK细胞、CHO细胞、昆虫细胞和鱼胚胎等。同时,不同外源功能性基因对重组Ⅶ因子活性和翻译后修饰对表达产量的影响也通过不同方法进行探究。本文从Ⅶ因子在凝血途径中的作用、重组表达重组Ⅶ因子和翻译后修饰对合成的影响3个方面对重组Ⅶ因子表达和合成机制研究进行了综述。
    Abstract: Haemophilia is caused by lack of coagulation factor VIII or IX in patients′ blood with inadequate hemostasis. Currently recombinant coagulation factor VII(rFVII)produced in different cells is used against clinical bleeding of haemophilia patients. To enhance the production and activity of rFVII, some eukaryotic cells such as baby hamster kidney(BHK), Chinese hamster ovary(CHO), insect cell and fish embryo, were used to express rFVII. Meanwhile, the effect of functional gene on the activity of rFVII and the limitation of rFVII production caused by post-translational modification were investigated by different methods. The role of rFVII in hemostasis, synthesis of rFVII in different eukaryotic cells and impact on production of post-translational modification are reviewed in this article.
  • [1] Davie EW,Ratnoff OD.Waterfall sequence for intrinsic blood clotting[J].Science,1964,145(3638):1310-1312.
    [2] Hoffman M,Pawlinski R.Hemostasis:old system,new players,new directions[J].Thromb Res,2014,133(Suppl 1):S1-S2.
    [3] Repke D,Gemmell CH,Guha A,et al.Hemophilia as a defect of the tissue factor pathway of blood coagulation:effect of factors VIII and IX on factor X activation in a continuous-flow reactor[J].PNAS,1990,87(19):7623-7627.
    [4] Roberts HR,Monroe DM,Escobar MA.Current concepts of hemostasis-implications for therapy[J].Anesthesiology,2004,100(3):722-730.
    [5] Dijk K,Fischer K,Bom JG,et al.Variability in clinical phenotype of severe haemophilia:the role of the first joint bleed[J].Haemophilia,2005,11(5):438-443.
    [6] Hedner U,Lee C.First 20 years with recombinant FVIIa(Novo-Seven)[J].Haemophilia,2011,17(1):172-182.
    [7] Coppola A, Di Capua M, Di Minno MND,et al.Treatment of hemophilia:a review of current advances and ongoing issues[J].J Blood Med,2010,1:183-195.
    [8] Nilsson I,Hedner U,Björlin G.Suppression of factor IX antibody in hemophilia B by factor IX and cyclophosphamide[J].Ann Intern Med,1973,78(1):91-95.
    [9] Hedner U,Nilsson I,Bergentz S.Various prothrombin complex concentrates and their effect on coagulation and fibrinolysis in vivo[J].Thromb Haemost,1976,35(2):386-395.
    [10] Hedner U, Nilsson I, Bergentz S. Studies on the thrombogenic activities in two prothrombin complex concentrates[J].Thromb Haemost,1979,42(3):1022-1032.
    [11] Osterud B,Miller-Andersson M,Abildgaard U,et al.The effect of antithrombin III on the activity of the coagulation factors VII,IX and X[J].Thromb Haemost,1976,35(2):295-304.
    [12] Hedner U,Glazer S,Pingel K,et al.Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy[J].Lancet,1988,2(8621):1193.
    [13] Lusher J,Ingerslev J,Roberts H,et al.Clinical experience with recombinant factor VIIa[J].Blood Coagul Fibrinolysis,1998,9(2):119-128.
    [14] Monroe DM,Hoffman M,Oliver JA,et al.Platelet activity of high-dose factor VIIa is independent of tissue factor[J].Br J Haematol,1997,99(3):542-547.
    [15] Hedner U.FactorVIIa and its potential therapeutic use in bleeding-associated pathologies[J].Thromb Haemost,2008,100(4):557-562.
    [16] Hoffman M.A cell-based model of coagulation and the role of factor VIIa[J].Blood Rev,2003,17(Suppl 1):S1-S5.
    [17] Lisman T,Mosnier LO,Lambert T,et al.Inhibition of fibrinolysis by recombinant factor VIIA in plasma from patients with severe hemophilia A[J].Blood,2002,99(1):175-179.
    [18] He S,Blomback M,Ekman BG,et al.The role of recombinant factor VIIa(FVIIa)in fibrin structure in the absence of FVIII/FIX[J].J Thromb Haemost,2003,1(6):1215-1219.
    [19] Hagen FS,Gray CL,O′Hara P,et al.Characterization of a cDNA coding for human factor VII[J].PNAS,1986,83(8):2412-2416.
    [20] Berkner K,Busby S,Davie E,et al.Isolation and expression of cDNAs encoding human factor VII[J].Cold Spring Harb Symp Quant Biol,1986,51:531-541.
    [21] Jurlander B,Thim L,Klausen NK,et al.Recombinant activated factor VII(rFVIIa):characterization,manufacturing,and clinical development[J].Semin Thromb Hemost,2001,27(4):373-383.
    [22] Hedner U,Ljundberg J,Lund-Hansen T.Comparison of the effect of plasma-derived and recombinant human FVIIa in vitro and in a rabbit model[J].Blood Coagul Fibrinolysis,1990,1(2):145-151.
    [23] Omasa T,Onitsuka M,Kim WD.Cell engineering and cultivation of Chinese hamster ovary(CHO)cells[J].Curr Pharm Biotechnol,2010,11(3):233-240.
    [24] Kim JY,Kim YG,Lee GM.CHO cells in biotechnology for production of recombinant proteins:current state and further potential[J].Appl Microbiol Biotechnol,2012,93(3):917-930.
    [25] Berkner KL.Expression of recombinant vitamin-k-dependent proteins in mammalian-cells factor-IX and factor-VII[J].Methods Enzymol,1993,222:450-477.
    [26] Kemball-Cook G,Garner I,Imanaka Y,et al.High-level production of human blood-coagulation factor-VII and factor-XI using a new mammalian expression vector[J].Gene,1994,139(2):275-279.
    [27] Kazama Y,Hamamoto T,Foster DC,et al.Hepsin,a putative membrane-associated serine-protease,activates human factor-VII and initiates a pathway of blood-coagulation on the cell-surface leading to thrombin formation[J].J Biol Chem,1995,270(1):66-72.
    [28] Halabian R,Roudkenar MH,Esmaeili NS,et al.Establishment of a cell line expressing recombinant factor VII and its subsequent conversion to active form FVIIa through hepsin by genetic engineering method[J].Vox Sang,2009,96(4):309-315.
    [29] Xiao W,Li F,Li C,et al.Construction of the expression vector for recombinant human coagulation factor VII[J].Vox Sang,2012,103(Suppl 1):145-145.
    [30] Xiao W,Li CQ,Xiao XP,et al.Expression and fast preparation of biologically active recombinant human coagulation factor VII in CHO-K1 cells[J].Genet Mol Res,2013,12(4):6813-6824.
    [31] Wajih N,Owen J,Wallin R.Enhanced functional recombinant factor VII production by HEK 293 cells stably transfected with VKORC1 where the gamma-carboxylase inhibitor calumenin is stably suppressed by shRNA transfection[J].Thromb Res,2008,122(3):405-410.
    [32] Mirzaahmadi S,Asaadi-Tehrani G,Bandehpour M,et al.Expression of recombinant human coagulation factor VII by the lizard Leishmania expression system[J].J Biomed Biotechnol,2011,2011:873-874.
    [33] Masroori N, Halabian R, Mohammadipour M, et al. High-level expression of functional recombinant human coagulation factor VII in insect cells[J].Biotechnol Lett,2010,32(6):803-809.
    [34] Hwang GL,Muller F,Rahman MA,et al.Fish as bioreactors:transgene expression of human coagulation factor VII in fish embryos[J].Mar Biotechnol,2004,6(5):485-492.
    [35] Bolt G,Kristensen C,Steenstrup TD.Posttranslational N-glycosylation takes place during the normal processing of human coagulation factor VII[J].Glycobiology,2005,15(5):541-547.
    [36] Bolt G,Steenstrup TD,Kristensen C.All post-translational modifications except propeptide cleavage are required for optimal secretion of coagulation factor VII[J].Thromb Haemost,2007,98(5):988-997.
    [37] Bolt G,Kristensen C,Steenstrup TD.More than one intracellular processing bottleneck delays the secretion of coagulation factor VII[J].Thromb Haemost,2008,100(2):204-210.
计量
  • 文章访问数:  1084
  • HTML全文浏览量:  3
  • PDF下载量:  2564
  • 被引次数: 0
出版历程
  • 刊出日期:  2015-10-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭